Atlanta group seeks partners

A delegation of Atlanta businesses is scheduled to arrive in Israel over the weekend to foster relations between US and Israeli biomedical companies.

By AVI KRAWITZ
November 2, 2006 07:50

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

A delegation of Atlanta businesses is scheduled to arrive in Israel over the weekend to foster relations between US and Israeli biomedical companies. The 5-day mission is being organized by the American-Israel Chamber of Commerce (AICC), which has been involved in over $150m. in contracts over the past year, and the Metro Atlanta Chamber of Commerce. Its aim is to promote Atlanta as a base for clinical trials of biomedical products. The delegation will visit several technology centers in the North and meet with Israeli governmental and business leaders, including investors in the technology and life science industries. They also will participate in next week's Prime Minister's Economic Conference and a conference on Alternative and Renewable Energy.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS